How the product works:
- activates GIP and GLP-1 receptors, enhancing glucose-dependent insulin secretion
- lowers blood glucose and improves metabolic control
- promotes weight loss by reducing appetite
- slows gastric emptying and regulates digestion
Who is recommended:
- patients with type 2 diabetes (as prescribed by a doctor)
- individuals with obesity in clinical research settings
- studied for reduction of cardiovascular risk in diabetic patients
Studies and research:
- SURPASS clinical trials confirmed significant reduction in HbA1c and body weight
- investigated as a promising therapy for obesity and metabolic syndrome
- FDA approved (2022) for type 2 diabetes treatment
Array
(
[actionUrl] => [[+assetsUrl]]action.php
[form] => admin@sacred-leaves.com,idrees@sacred-leaves.com,info@sacred-leaves.com
[formSelector] => ajax_form
[frontend_css] => [[+assetsUrl]]css/default.css
[frontend_js] => [[+assetsUrl]]js/default.js
[objectName] => AjaxForm
[snippet] => FormIt
[hooks] => email
[emailTpl] => tpl.simple-email
[emailSubject] => Сообщение с сайта
[emailTo] => verfut@yandex.ru
[validate] => username:required, tel:required
[validationErrorMessage] => В форме содержатся ошибки!
[successMessage] => Сообщение успешно отправлено
)
